Skip to main content
Top
Published in: Diabetologia 2/2019

01-02-2019 | Article

Association between maternal diabetes, being large for gestational age and breast-feeding on being overweight or obese in childhood

Authors: Padma Kaul, Samantha L. Bowker, Anamaria Savu, Roseanne O. Yeung, Lois E. Donovan, Edmond A. Ryan

Published in: Diabetologia | Issue 2/2019

Login to get access

Abstract

Aims/hypothesis

This study aimed to examine the association of maternal diabetes, being large for gestational age (LGA) and breast-feeding with being overweight or obese in pre-school-aged children.

Methods

Data on height and weight at the time of their pre-school (age 4–6 years) immunisation visit between January 2009 and August 2017, as well as breast-feeding status in the first 5 months of life, for 81,226 children born between January 2005 and August 2013 were linked with maternal hospitalisation and outpatient records and birth registry data. Children were grouped into six categories based on maternal diabetes status during pregnancy (no diabetes, gestational diabetes or pre-existing diabetes) and birthweight (appropriate for gestational age [AGA] or LGA). WHO criteria were used to identify children who were overweight or obese.

Results

There were 69,506 children in the no diabetes/AGA group (control), 5926 in the no diabetes/LGA group, 4563 in the gestational diabetes/AGA group, 573 in the gestational diabetes/LGA group, 480 in the pre-existing diabetes/AGA group and 178 in the pre-existing diabetes/LGA group. The rate of being overweight/obese at pre-school age ranged from 20.5% in the control group to 42.9% in the gestational diabetes/LGA group. The adjusted attributable risk per cent for LGA alone (39.4%) was significantly higher than that for maternal gestational diabetes (16.0%) or pre-existing diabetes alone (15.1%); the risk for the combinations of gestational diabetes/LGA and pre-existing diabetes/LGA were 50.1% and 39.1%, respectively. Further stratification of the pre-existing diabetes groups found the prevalence of being overweight/obese was 21.2% in the type 1/AGA group, 31.4% in the type 1/LGA group (similar to those in the no diabetes groups), 26.7% in the type 2/AGA group and 42.5% in the type 2/LGA group. Breast-feeding was associated with a lower likelihood of being overweight/obese in childhood in all groups except gestational diabetes/LGA and pre-existing diabetes/LGA (both type 1 and type 2).

Conclusion/interpretation

LGA is a stronger marker for risk of being overweight/obese in early childhood, compared with maternal diabetes during pregnancy. Rates of being overweight/obese in childhood were highest in LGA children born to mothers with gestational diabetes or pre-existing type 2 diabetes. Breast-feeding was associated with a lower risk of being overweight/obese in childhood in the majority of children; however, this association was not maintained in LGA children of mothers with diabetes.
Appendix
Available only for authorised users
Literature
19.
go back to reference Allen VM, Dodds L, Spencer A et al (2012) Application of a national administrative case definition for the identification of pre-existing diabetes mellitus in pregnancy. Chronic Dis Inj Can 32(3):113–120PubMed Allen VM, Dodds L, Spencer A et al (2012) Application of a national administrative case definition for the identification of pre-existing diabetes mellitus in pregnancy. Chronic Dis Inj Can 32(3):113–120PubMed
32.
Metadata
Title
Association between maternal diabetes, being large for gestational age and breast-feeding on being overweight or obese in childhood
Authors
Padma Kaul
Samantha L. Bowker
Anamaria Savu
Roseanne O. Yeung
Lois E. Donovan
Edmond A. Ryan
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4758-0

Other articles of this Issue 2/2019

Diabetologia 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine